Skip to main content

Day: August 24, 2020

ADLPartner : Déclaration des transactions sur actions propres réalisées du 17 au 21 août 2020

ADLPartnerSociété anonyme à directoire et conseil de surveillance au capital de 6 478 836 euros3, avenue de Chartres 60500 – CHANTILLY393 376 801 R.C.S. CompiègneDéclaration des transactions sur actions propres réalisées du 17 au 21 août 2020Présentation agrégée par jour et par marchéDétail transaction par transactionRelations Investisseurs & Informations financièresTel : +33 1 41 58 72 03 – Courriel : relations.investisseurs@adlpartner.frADLPartner est cotée sur Euronext Paris – Compartiment CCodes ISIN : FR0000062978-ALP – Bloomberg : ALP FP – Reuters : ALDP.PAwww.adlpartner.comPièce jointeADLPartner_rachats_actions_24082020

Continue reading

Nexans: Share offering reserved for Nexans Group employees

Paris, France, August 24, 2020 – Nexans 2020 will implement a new employee shareholding plan before the end of the year.This transaction will result in a share capital increase of Nexans company of a maximum five hundred thousand (500,000) shares. The issuance of new shares is scheduled for 13 November 2020.The main terms and conditions of this employee shareholding plan are described hereinafter.PURPOSE OF THE TRANSACTIONThis shareholding plan, which is in line with the policy of developing the employee shareholding within the Group will cover twenty five (25) countries. Nexans wishes to associate closely its employees in France and abroad with the Group’s development.This transaction, called “NEXANS Act 2020”, will consist in a unique offer including a leverage effect and an investment guarantee which could be adjusted according...

Continue reading

Monument fait le point sur la mine d’or Selinsing en Malaisie

VANCOUVER, Colombie-Britannique, 24 août 2020 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V : MMY et FSE : D7Q1) (« Monument » ou la « Société ») fait le point sur sa mine d’or de Selinsing entièrement détenue dans l’État de Pahang, en Malaisie.Cathy Zhai, Présidente-directrice générale, a déclaré : « Selinsing est notre principal projet de production aurifère. Nous continuons de travailler dur sur plusieurs alternatives de financement afin de mettre à niveau l’usine de traitement de l’or de Selinsing qui traitera le minerai sulfuré, concrétisant la nouvelle production de la mine. En attendant, notre équipe opérationnelle se concentre également sur la durabilité de la production aurifère pour combler l’écart pendant la conversion, améliorer la conception du projet des sulfures et réaliser des tests...

Continue reading

Monument veröffentlicht neueste Informationen über Goldmine Selinsing in Malaysia

VANCOUVER, British Columbia (Kanada), Aug. 24, 2020 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY und FSE: D7Q1) („Monument“ oder das „Unternehmen“) veröffentlicht neueste Informationen zur Goldmine Selinsing im Bundesstaat Pahang, Malaysia, die sich zu 100 % im Besitz des Unternehmens befindet.CEO und President Cathy Zhai sagte: „Selinsing ist unser Hauptprojekt im Bereich der Goldproduktion. Wir arbeiten weiterhin intensiv an verschiedenen Finanzierungsalternativen, um die Goldverarbeitungsanlage in Selinsing zu modernisieren, in der Sulfiderz behandelt wird, was eine neue Ära der Produktion in der Mine einläuten wird. In der Zwischenzeit konzentriert sich unser Betriebsteam auch auf die Nachhaltigkeit der Goldproduktion, um die Lücke während der Umstellung zu schließen, das Projektdesign in Hinsicht auf Sulfid zu verbessern...

Continue reading

Injectable Drug Delivery Market Worth USD 1,251.28 Billion and 12.9% CAGR; Rising Cases of COVID-19 Pandemic to Promote Growth, says Fortune Business Insights™

Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) — The global injectable drug delivery market is anticipated to rise at a CAGR of 12.9% to reach USD 1,251.28 billion by the end of 2027 owing to the increasing prevalence of various diseases and the need for easy drug delivery to various target sites. Injectable drug delivery helps to provide effective drug delivery experience with speedy delivery. It is also considered as one of the most efficient routes of administration, thus ensuring improved patient experience.As per a report by Fortune Business Insights, titled, “Injectable Drug Delivery Market Size, Share & Industry Analysis, By Device Type (Conventional Injectable, Pre-filled syringes, Auto- injectors, Pen Injectors, and Wearable), By Product Type (Freeze-dried Products, Injectable Sterile Products), By End User (Hospitals, Homecare...

Continue reading

Algernon Updates Market on Analyst Coverage by Mackie Research

VANCOUVER, British Columbia, Aug. 24, 2020 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is providing the clarification that the recently published report on the Company initiated by Mackie Research Capital Corporation (“Mackie”), is an independent research report and further the Company does not accredit the target share price reported by Mackie. Further, the recommendations and target are the opinions of Mackie and are independent of the Company.This update was provided at the request of the Investment Industry Regulatory Organization of Canada.About Algernon Pharmaceuticals Inc. Algernon is a drug re-purposing company that investigates safe, already approved drugs for new disease applications, moving...

Continue reading

Crédit Agricole d’Ile-de-France : communiqué de mise à disposition du rapport financier au 30.06.2020

Communiqué de mise à disposition du rapport financier semestriel du Crédit Agricole d’Ile-de-France Paris, le 24 août 2020Le Crédit Agricole d’Ile-de-France  annonce ce jour avoir mis à la disposition du public et déposé auprès de l’Autorité des marchés financiers son rapport financier semestriel au 30 juin 2020. Le rapport financier semestriel peut être consulté  sur   le  site  internet   à  l’adresse   www.ca-paris.com,   dans   la   rubrique « Finance / Informations Financières ».Pièces jointesCommuniqué de mise à disposition du rapport financier semestriel 2020 – CAIDF202006 Rapport financier semestriel -VDEF

Continue reading

Cardiac Pacemakers Market to Reach US$ 5,131.9 Mn by 2026, Increasing FDA Approvals to Enable Growth, says Fortune Business Insights

Pune, Aug. 24, 2020 (GLOBE NEWSWIRE) — The Global Cardiac Pacemakers Market was valued at US$ 4,064.9 Mn in 2018. Fortune Business Insights has predicted that the market will reach US$ 5,199.7 Mn by the end of 2026, thereby exhibiting a CAGR of 3.0%. The market is likely to grow in the coming years due to increasing cases of sudden cardiac deaths.The cardiac pacemakers have gained popularity in recent times due to their application in monitoring patient heartbeat using electrical stimulation. Cardiac Pacemakers have the ability to operate over a short or longer period of time, depending upon the application. The ability of cardiac pacemakers to provide diagnostic information about the heart has led to a rise in uptake of the device, globally.Request a Sample Copy of the Research Report: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/cardiac-pacemakers-market-100682Technological...

Continue reading

J. Craig Holding Corp. Official Name Change Request Has Been Reserved With FINRA

HUNTINGTON BEACH, CA, Aug. 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE ‒ J. Craig Holding Corp., fka Ultra Pure Water Technologies, Inc. (OTC: UPWT), an accelerator and incubator for innovative businesses, intellectual properties and assets, was informed the official name change has been reserved by FINRA for 120 days allowing the company to proceed with both the name and ticker change. Caren Currier, CFO, stated, “Even though we have 120 days reserved with FINRA, management wishes to expedite this action in order to officially change the company name and receive a ticker symbol that will better reflect the company’s current business strategy. As previously mentioned, this is a critical piece of J. Craig Holding Corp’s transition process from the old business of Ultra Pure Water Technologies.”The holding company, which will have...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.